STJ : Analysis & Opinions

  1. MedTech Industry Stock Update - Jan 2014 - Industry Outlook

    January 7, 2014
    MedTech Industry Stock Update - Jan 2014 - Industry Outlook
  2. MedTech Industry Stock Update - Sept 2013 - Industry Outlook

    September 10, 2013
    MedTech Industry Stock Update - Sept 2013 - Industry Outlook
  3. Medtronic Marking Time

    August 20, 2013
    Medtronic looks stuck in low-growth mode for now, but the shares look undervalued.
  4. Earnings Expectations for the Week of July 15

    July 14, 2013
    The earnings season ramps up this week, providing plenty of perspective on how the financial and technology sectors fared ...
  5. STJ Rolls Out Accent MRI in Japan - Analyst Blog

    June 28, 2013
    St. Jude Medical has launched its Accent MRI Pacemaker and the Tendril MRI lead in Japan.
  6. CE Mark for St. Jude's CRT-D - Analyst Blog

    June 25, 2013
    St. Jude has won the European CE Mark approval for its MultiPoint Pacing Quadra Assura MP CRT-D, featuring the Quartet lead.
  7. BSX Commences U.S. INTREPID Trial - Analyst Blog

    June 18, 2013
    Boston Scientific initiates clinical trial for its Vercise DBS System in the U.S.
  8. St. Jude Expands Neuro Offerings - Analyst Blog

    June 10, 2013
    St. Jude has entered into an exclusive distribution agreement with Spinal Modulation to sell its Axium Neurostimulator System ...
  9. Medtronic Still Reporting Weak Growth, But A Relatively Rare ...

    May 22, 2013
    Medtronic continues to suffer with weak core markets, but business seems to be getting slowly better and valuation is not ...
  10. Pharma Is Doing All The Pulling For Johnson & Johnson

    April 17, 2013
    Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
  11. Medtronic Initiates Clinical Study - Analyst Blog

    January 30, 2013
    Leading medical device player Medtronic Inc. (MDT) continues to focus on the promising neuromodulation business. The company ...
  12. St. Jude Beats Estimates - Analyst Blog

    January 23, 2013
    St. Jude Medical's (STJ) fourth-quarter adjusted earnings per share of 92 cents topped the Zacks Consensus Estimate by 2 ...
  13. CE Mark for St. Jude's Products - Analyst Blog

    January 22, 2013
    St. Jude Medical (STJ) has received CE Mark approval for two of its devices viz. the AMPLATZER Amulet Left Atrial Appendage ...
  14. Earnings Preview: St. Jude - Analyst Blog

    January 21, 2013
    St. Jude Medical Inc. (STJ) is set to report its fourth-quarter 2012 results before the opening bell on Wednesday, Jan 23. ...
  15. Medtronic Expands AF Product Line - Analyst Blog

    January 17, 2013
    Leading medical devices player, Medtronic (MDT) has strengthened its growing atrial fibrillation (AF) business. This is on ...
  16. Cyberonics Attains New Landmark - Analyst Blog

    December 24, 2012
    Neuromodulation company, Cyberonics (CYBX) announced the 100,000th patient implant of its Vagus Nerve Stimulation (VNS) Therapy ...
  17. MDT Issues Symplicity Trial Data - Analyst Blog

    December 20, 2012
    Leading medical devices player, Medtronic (MDT) recently announced the online availability of encouraging data from a randomized ...
  18. BSX Initiates Ingevity Trial - Analyst Blog

    December 19, 2012
    Boston Scientific Corporation (BSX) recently commenced a trial for its next-generation Ingevity pacing leads. The first patient ...
  19. New Product from Medtronic - Analyst Blog

    December 12, 2012
    Medtronic Inc (MDT), the world's leading spinal technology company, announced the launch of the latest addition to its cervical ...
  20. Edward's Perimount Mitral in China - Analyst Blog

    December 3, 2012
    Edwards Lifesciences Corporation (EW), a leading developer of heart valves and hemodynamic monitoring, recently received ...
  21. Early Research Calls

    November 30, 2012
    New York, November 30th (TradersHuddle.com) – Following are some of the upgrades and downgrades before the market open. Brown-Forman ...
  22. Cyberonics Reiterated at Outperform - Analyst Blog

    November 29, 2012
    We recently maintained our Outperform recommendation on Cyberonics (CYBX), a major neuromodulation company, with a target ...
  23. Upgrades & Downgrades

    November 29, 2012
    New York, May 14th (TradersHuddle.com) - The following are top upgrades and downgrades before the market opens. Nokia ...
  24. Volcano Reiterated at Neutral - Analyst Blog

    November 28, 2012
    We have reaffirmed our Neutral recommendation on Volcano Corporation (VOLC) with a target price of $28.00 following its third-quarter ...
  25. Medtronic's Growth Looks Good, But Can It Last?

    November 22, 2012
    Medtronic may not be a super grower anymore, but it's doing better than the Street seems to acknowledge
  26. Salesforce.com Among the NYSE's Biggest Movers on November 21, ...

    November 21, 2012
    The Nasdaq is unchanged, the S&P 500 has increased 0.1% and the Dow is trading up 0.2% this morning. Also known as the "Big ...
  27. A Disappointing 3Q for Volcano - Analyst Blog

    November 7, 2012
    Volcano Corporation (VOLC) reported earnings per share (EPS) of 4 cents in the third quarter of fiscal 2012.The results were ...
  28. Greatbatch Beats Ests, Profits Dip - Analyst Blog

    October 26, 2012
    Greatbatch, Inc.'s (GB) third-quarter 2012 adjusted earnings per share of 46 cents beat the Zacks Consensus Estimate of 44 ...
  29. A Challenging 3Q for Edwards - Analyst Blog

    October 22, 2012
    Edwards Lifesciences Corporation (EW) reported earnings of 58 cents per share in the third quarter of 2012 (within the guidance ...
  30. Healthcare Stocks, Including Abbott, Making Big Moves on October ...

    October 17, 2012
    The Nasdaq has remained steady, the S&P 500 is up 0.3% and the Dow remains relatively unchanged so far today. The healthcare ...
  31. New Spine Device from Medtronic - Analyst Blog

    October 9, 2012
    To overcome the ongoing difficulties and challenges in the spinal business, leading medical device player Medtronic, Inc. ...
  32. MedTech Industry Stock Outlook - Oct. 2012 - Zacks Analyst Interviews

    October 2, 2012
    The global medical devices industry is fairly large, intensely competitive and highly innovative. A regulated industry, MedTech ...
  33. MedTech Industry Stock Outlook - Oct. 2012 - Industry Outlook

    October 2, 2012
    The global medical devices industry is fairly large, intensely competitive and highly innovative. A regulated industry, MedTech ...
  34. Medtronic Expands in China - Analyst Blog

    October 1, 2012
    Recently, the medical device players have shifted focus towards emerging markets, especially China. Medtronic (MDT), in line ...
  35. Cyberonic Ventures in Germany - Analyst Blog

    September 21, 2012
    Leading neuromodulation company, Cyberonics Inc. (CYBX) made an initial investment of €2 million in a German privately-held ...
  36. Gilead Among Healthcare's Biggest Movers on September 14, 2012

    September 14, 2012
    The market has been doing well after the morning's trading. The Nasdaq has risen 1.1%; the S&P 500 has increased 0.6%; and ...
  37. Boston Scientific Remains Neutral - Analyst Blog

    September 7, 2012
    We have reaffirmed our Neutral recommendation on Boston Scientific Corporation (BSX) with a target price of $5.75 following ...
  38. Greatbatch Remains Neutral - Analyst Blog

    September 4, 2012
    We reiterate our Neutral recommendation on Greatbatch, Inc. (GB) following its second quarter results. In the reported quarter, ...
  39. Volcano Corporation Remains Neutral - Analyst Blog

    September 4, 2012
    We have reaffirmed our Neutral recommendation on Volcano Corporation (VOLC) with a target price of $29.00 following its second-quarter ...
  40. MDT Progresses in CoreValve Trial - Analyst Blog

    September 4, 2012
    Leading medical devices player, Medtronic (MDT) has progressed with respect to its CoreValve US pivotal trial. The company ...
  41. Cyberonics Upgraded to Outperform - Analyst Blog

    September 4, 2012
    We recently upgraded our recommendation on Cyberonics (CYBX), a major neuromodulation company, to Outperform primarily based ...
  42. The Week In Healthcare

    August 31, 2012
    Although this has been a solid year for med-tech, some sub-sectors are starting to lag a bit during this late summer rally.
  43. Encouraging 1Q for Cyberonics - Analyst Blog

    August 29, 2012
    Cyberonics (CYBX), a neurological device maker, reported earnings per share ("EPS") of 29 cents in the first quarter of fiscal ...
  44. Earnings Preview: Cyberonics - Analyst Blog

    August 24, 2012
    Leading neuromodulation company, Cyberonics Inc. (CYBX) is scheduled to report its first quarter fiscal 2013 results before ...
  45. Earnings Scorecard: Edwards - Analyst Blog

    August 6, 2012
    The announcement of Edwards Lifesciences' (EW) second quarter fiscal 2012 results as on July 24, 2012, has led analysts to ...
  46. Volcano's Mixed 2Q, Guides Down - Analyst Blog

    August 3, 2012
    Volcano Corporation (VOLC) reported EPS of 6 cents in the second quarter of fiscal 2012, ahead of the Zacks Consensus Estimate ...
  47. More Healthy Alternatives To Zimmer

    July 30, 2012
    Zimmer has turned to cost cutting to keep total profit growth moving positively forward, but doesn't appear to have any answers ...
  48. Greatbatch's 2Q Mixed, Profit Drops - Analyst Blog

    July 26, 2012
    Greatbatch, Inc. (GB) reported second-quarter 2012 adjusted (excluding one-time items) earnings per share of 43 cents, in ...
  49. BSX Incurs Loss, Hit by Charges - Analyst Blog

    July 26, 2012
    Boston Scientific (BSX) reported a net loss of $3.4 billion or $2.39 per share in the second quarter of 2012, a disappointment ...
  50. Zimmer Posts Mixed 2Q, Tightens View - Analyst Blog

    July 26, 2012
    Zimmer Holdings (ZMH) reported earnings per share ("EPS") of $1.22 in the second quarter of fiscal 2012 compared with $1. ...
  51. Edwards' Mixed 2Q, Revises View - Analyst Blog

    July 25, 2012
    Edwards Lifesciences Corporation (EW) reported net income of $67.8 million or 57 cents per share in the second quarter of ...
  52. The Week Ahead In Healthcare

    July 24, 2012
    Healthcare stocks continue to outperform this year. However, a lot of this outperformance seems to be coming from lower tax ...
  53. Earnings Preview: EW - Analyst Blog

    July 23, 2012
    Edwards Lifesciences Corporation (EW) is scheduled to release its second quarter fiscal 2012 results on Tuesday, July 24, ...
  54. Greatbatch to Build R&D Centre - Analyst Blog

    July 20, 2012
    Medical technologies company, Greatbatch Inc. (GB) recently announced that it will set up an Active Implantable Medical Device ...
  55. Healthcare Stocks Making Big Moves on July 18, 2012

    July 18, 2012
    The morning has been good for the market. The Nasdaq has risen 1.2%; the S&P 500 is up 0.6%; and the Dow has moved up 0.7%. ...
  56. The Week Ahead In Healthcare

    July 16, 2012
    Healthcare stocks continue to outperform this year. Here's what you can expect for the sector in the week ahead.
  57. Greatbatch to Relocate Ortho Unit - Analyst Blog

    July 5, 2012
    Medical technology company, Greatbatch Inc. (GB) recently proposed to relocate Greatbatch Medical's orthopedics manufacturing ...
  58. Obamacare's Future in the Balance - Analyst Blog

    June 27, 2012
    The country is awaiting a major event later this week with the Supreme Court scheduled to deliver a decision on the Patient ...
  59. MedTech Industry Stock Outlook - June 2012 - Industry Outlook

    June 18, 2012
    Over the recent past, medical technology (MedTech) players have faced the brunt of exigent economic conditions and a precarious ...
  60. MedTech Industry Stock Outlook - June 2012 - Zacks Analyst Interviews

    June 18, 2012
    Over the recent past, medical technology (MedTech) players have faced the brunt of exigent economic conditions and a precarious ...
  61. Cyberonics Beats, Guides In Line - Analyst Blog

    June 7, 2012
    Cyberonics (CYBX), a neurological device maker, reported earnings per share ("EPS") of 38 cents in the fourth quarter of ...
  62. Volcano Corp. Misses by a Penny - Analyst Blog

    May 3, 2012
    Volcano Corp. Misses by a Penny - Analyst Blog
  63. NVEC Still Searching For Commercial Relevance

    March 16, 2012
    NVEC has exciting technology, but much less exciting revenue.
  64. Value At Abbott Labs Balances A Lot Of Growth Optimism

    February 14, 2012
    Growth expectations may be too high for Abbott.
  65. Top Dividends: The Best Dividend Stocks For 2012

    January 30, 2012
    2012 might see investors playing the same strategy so popular in 2011: Dividend stocks.
  66. 2011 - Another Sick Year For Larger Med-Tech

    December 29, 2011
    Larger healthcare companies are still getting sickly returns in the market.
  67. Medtronic May Be A Heavyweight, But It Can Still Hit Hard

    November 28, 2011
    Medtronic has gone from over-loved to under-loved, and value investors should take note.
  68. The Perpetual Boston Scientific Turnaround Story

    August 4, 2011
    Another quarter brings another hope for better days at BSX.
  69. Baxter Looking Pale In Comparison To Rivals

    July 26, 2011
    A handful of health care peers trade at more appealing earnings multiples than Baxter.
  70. Drugs Don't Cure All That Ails J&J

    July 20, 2011
    JNJ's performance is mediocre, as are its investment prospects.
  71. Better Budgets, Better Times For Robots

    July 12, 2011
    With healthier budgets at hospitals, robots are looking better and better.
  72. Medtronic Still Muddling Through

    May 27, 2011
    Medtronic is going nowhere fast, but the quality hasn't left.
  73. February's Healthcare Winners

    March 3, 2011
    Check out February's best Performing Healthcare Stocks.
  74. Medtronic's Midlife Crisis

    February 24, 2011
    Medtronic lacks growth, but quality is still in place.
  75. Med-Tech Choice Is Simply Intuitive

    January 25, 2011
    Intuitive posted reassuring growth, but needs to continue penetrating new markets.
  76. 2010: The Year In Med-Tech Deals

    December 29, 2010
    2010 was a relatively slow year for deals in the med-tech sector.
  77. Boston Scientific Has A Long Road Back

    October 21, 2010
    Boston Scientific is priced to do almost nothing, but that may underestimate the potential of operating improvement.
  78. Money To Be Made In Medical Devices

    September 22, 2010
    New advances in medical devices will not only help patients live better lives, but they'll power portfolios as well.
  79. It's Not All About The Housing Market

    September 17, 2010
    It may seem hopeless investing in stocks today, but some businesses thrive despite a bad housing market and high unemployment.
  80. Medtronic Looks A Little Woozy

    August 26, 2010
    It seems that the expectations for Medtronic are so low that long-term investors have little to fear.
  81. Stryker In Oversold Territory

    August 26, 2010
    A pessimistic stock market and weak Medtronic results have sent shares of Stryker back toward their lows over the last year.
  82. Medtronic - Life In The Crosshairs

    May 28, 2010
    Medtronic will never be the growth stock it once was, but it is a high-quality medical-technology name that investors should ...
  83. Shopping Time In Medical Technology?

    May 6, 2010
    Is Medtronic's acquisition of ATS Medical the beginning of another M&A wave in med-tech?
  84. Three Growth Med-Techs Show Their Cards

    May 6, 2010
    Three quality growth med-techs reported earnings Monday evening, May 3, with varying degrees of performance.
  85. Three "Triple Play" Healthcare Stocks

    May 5, 2010
    These stocks have all the numbers that momentum investors love.
  86. Can Boston Scientific Ever Get It Right?

    April 30, 2010
    Boston Scientific has been a perrenial underperformer. Can the company turn it around?
  87. Boston Scientific Looking Sickly

    April 29, 2010
    Boston Scientific's history will go a long way in paving the path for a recovery, but until investors see those signs, this ...
  88. Betting On Boston Scientific

    March 17, 2010
    The BSX recall has caused the stock to sell off, but this might be an opportunity to buy at a great price.
  89. 4 More Stocks The Insiders Love

    February 12, 2010
    These insider buys are worth a second look.
  90. Keeping Pace At Medtronic

    November 27, 2009
    The medical device market hasn't escaped the recession, but it's coming back strong.
  91. Medical Devices: Cure For Ailing Portfolios?

    February 27, 2009
    Find out how these medical device makers may resuscitate your ailing portfolio.
  92. Medtronic's Mixed Medical Bag

    February 24, 2009
    Medtronic stock offers potential gains - if it can survive the competition.
  93. One More Step For MannKind

    December 4, 2008
    This biotech's inhaled insulin seems to work, but will it sell?
  94. Medtronic Sneezes, Investors Feel Sick

    November 24, 2008
    Is Medtronic's stumble a buying opportunity?
  95. Take A Pass On Boston Scientific

    October 28, 2008
    With so many high-quality medical device stocks trading lower, the argument for Boston Scientific is less compelling.
  96. A Heartbeat Away (MDT, STJ, ZOLL, CSCX)

    March 8, 2007
    A look at medical companies that stand to benefit from the aging of the baby boomer generation.
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center